Catherine Sautès-Fridman mostly deals with Immune system, Immunology, Cancer research, Tumor microenvironment and Immunotherapy. The concepts of her Immune system study are interwoven with issues in Immunohistochemistry, Cancer, Cell, Bioinformatics and Cytotoxic T cell. Her study in the field of Stromal cell and Animal tumor also crosses realms of Kynurenine pathway.
Tumor microenvironment is frequently linked to Chemokine in her study. Her Chemokine research incorporates themes from Cytokines metabolism, Lymphatic system, Pathology, Disease free survival and Cancer type. Her research in Immunotherapy intersects with topics in T cell and Follicular dendritic cells.
Catherine Sautès-Fridman spends much of her time researching Immune system, Immunology, Cancer research, Tumor microenvironment and Cancer. Her Immune system study combines topics in areas such as Inflammation, Cytotoxic T cell and Stromal cell. Her Cancer research research integrates issues from Immunohistochemistry, Cell, T cell, Colorectal cancer and Primary tumor.
Her research integrates issues of Acquired immune system, Bioinformatics, Immunity, Chemokine and Flow cytometry in her study of Tumor microenvironment. Her Cancer research includes elements of Lung cancer, Clinical trial, Pathology and Germinal center. She mostly deals with Lymphatic system in her studies of Pathology.
The scientist’s investigation covers issues in Cancer research, Immune system, Tumor microenvironment, Immunotherapy and Cancer. Her Cancer research research includes elements of T cell, Antigen presentation, Complement system and Complement. Catherine Sautès-Fridman studies Immune system, namely Immune checkpoint.
Her work on Tumor-associated macrophage as part of general Tumor microenvironment study is frequently connected to Vulnerability, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Catherine Sautès-Fridman usually deals with Immunotherapy and limits it to topics linked to Cytotoxic T cell and Sarcoma. Her study looks at the relationship between Cancer and fields such as Lymphatic system, as well as how they intersect with chemical problems.
Catherine Sautès-Fridman mainly investigates Cancer research, Immune system, Immunotherapy, Immune checkpoint and Cancer immunotherapy. Her study in Tumor microenvironment and Melanoma is carried out as part of her studies in Cancer research. Her Tumor microenvironment study is concerned with the field of Cancer as a whole.
Her Melanoma research includes themes of Stromal cell and B cell. Her Immune system study incorporates themes from Gene expression profiling, Carcinogenesis, Gene, Immunosuppression and Hepatocellular carcinoma. Her Ipilimumab research is multidisciplinary, incorporating elements of Biomarker and Nivolumab.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman;Franck Pagès;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Jérôme Galon.
Nature Reviews Cancer (2012)
Immune infiltration in human tumors: a prognostic factor that should not be ignored.
Pagès F;Galon J;Galon J;Galon J;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Tartour E.
Oncogene (2010)
The immune contexture in cancer prognosis and treatment
Wolf H Fridman;Wolf H Fridman;Wolf H Fridman;Laurence Zitvogel;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Guido Kroemer.
Nature Reviews Clinical Oncology (2017)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht;Nicolas A. Giraldo;Nicolas A. Giraldo;Nicolas A. Giraldo;Laetitia Lacroix;Laetitia Lacroix;Laetitia Lacroix;Bénédicte Buttard;Bénédicte Buttard;Bénédicte Buttard.
Genome Biology (2016)
The structure of a human type III Fcgamma receptor in complex with Fc
Sergei Radaev;Shawn Motyka;Wolf-Herman Fridman;Catherine Sautes-Fridman.
Journal of Biological Chemistry (2001)
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
Fabrice Benchetrit;Arnaud Ciree;Virginie Vives;Guy Warnier.
Blood (2002)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman;Jérôme Galon;Franck Pagès;Eric Tartour.
Cancer Research (2011)
A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: Analysis of 83 cases
Sophie Camilleri-Broët;Emmanuelle Crinière;Philippe Broët;Vincent Delwail.
Blood (2006)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang.
Nature (2020)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova;Julien Cherfils-Vicini;Diane Damotte;Lucile Crozet.
Cancer Research (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
Sorbonne University
Université Paris Cité
Université Paris Cité
Cornell University
Sorbonne University
Institut Gustave Roussy
Inserm : Institut national de la santé et de la recherche médicale
Institut Gustave Roussy
Inserm : Institut national de la santé et de la recherche médicale
Publications: 89
Karlsruhe Institute of Technology
Hong Kong Baptist University
Facebook (United States)
University of Illinois at Urbana-Champaign
University of Oklahoma
University of St Andrews
University of British Columbia
Agricultural Research Service
Hokkaido University
Lamont-Doherty Earth Observatory
Inserm : Institut national de la santé et de la recherche médicale
Stetson University
University of Padua
University of Arizona
University of Haifa
Wesleyan University